KR102170850B1 - A composition for treating acne or improving acne skin - Google Patents
A composition for treating acne or improving acne skin Download PDFInfo
- Publication number
- KR102170850B1 KR102170850B1 KR1020200078644A KR20200078644A KR102170850B1 KR 102170850 B1 KR102170850 B1 KR 102170850B1 KR 1020200078644 A KR1020200078644 A KR 1020200078644A KR 20200078644 A KR20200078644 A KR 20200078644A KR 102170850 B1 KR102170850 B1 KR 102170850B1
- Authority
- KR
- South Korea
- Prior art keywords
- composition
- extract
- purslane
- ginger
- broccoli
- Prior art date
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/82—Theaceae (Tea family), e.g. camellia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9068—Zingiber, e.g. garden ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/06—Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9794—Liliopsida [monocotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/592—Mixtures of compounds complementing their respective functions
- A61K2800/5922—At least two compounds being classified in the same subclass of A61K8/18
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Birds (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Dispersion Chemistry (AREA)
- Dermatology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
본 발명은 여드름 치료용 또는 피부개선용 조성물에 관한 것이다.The present invention relates to a composition for treating acne or improving skin.
여드름(심상성 좌창: acne vulgaris)은 청소년 및 성인에게서 흔히 나타나는 피부 질환으로서 피부의 피지선에 나타나는 염증성 질환이다.Acne (acne vulgaris) is a common skin disease in adolescents and adults, and is an inflammatory disease in the sebaceous glands of the skin.
국민건강보험공단이 2010년부터 2015년까지 지급한 요양급여와 관련된 자료를 분석한 결과, 주진단명으로 여드름 치료를 받은 인원은 2015년 110,758명으로 집계되었는데, 이는 2010년의 100,935명과 대비할 때 약 10% 증가한 것이다. 전체 여드름 치료를 받은 인원 중에서 20대가 43.1%로 가장 많았고, 이어서 10대가 31.1%로 두번째로 많았다.As a result of analyzing data related to medical care benefits paid by the National Health Insurance Corporation from 2010 to 2015, the number of people who received acne treatment as the main diagnosis was counted as 110,758 in 2015, compared to 100,935 in 2010. % Increase. Among the total number of acne treatments, 20s were the most common at 43.1%, followed by teens at 31.1%.
여드름의 원인과 종류는 성별과 연령대별로 상이하게 나타난다. 청소년기에는 호르몬의 변화가 여드름 발생의 주요 원인이며, 이마, 코와 같이 T 존이라 불리는 부위에 주로 나타난다.The causes and types of acne appear differently by gender and age group. Hormonal changes in adolescence are the main cause of acne, and they appear mainly in areas called T zones such as forehead and nose.
반면, 성인의 여드름은 주로 스트레스, 음주, 불규칙한 생활습관 등 복합적인 이유로 발생하는 경우가 많고, 볼, 턱, 이마, 목 등 신체의 다양한 부위에서 발생한다. 성인의 여드름은 땀 또는 노폐물로 인하여 막힌 모공에서 발생하며, 재발율도 높다.On the other hand, acne in adults is often caused by complex reasons such as stress, drinking, and irregular lifestyle habits, and occurs in various parts of the body such as cheeks, chin, forehead, and neck. Adult acne occurs in pores clogged by sweat or waste products, and the recurrence rate is high.
여드름이 발생하고 나서 그대로 방치하는 경우, 여러 가지 문제가 발생할 수 있다. 여드름이 단순 염증에 그치는 것이 아니라, 피부 진피층에까지 문제를 일으켜 여드름 자국, 여드름 흉터, 넓어진 모공 등 다양한 2차 손상을 일으키기도 한다.If acne occurs and is left unattended, various problems can occur. Acne is not just an inflammation, but also causes problems in the dermal layer of the skin, causing various secondary damage such as acne marks, acne scars, and enlarged pores.
여드름은 샐활습관이 주 원인이 되는 경우가 많기 때문에, 일상 생활에서 꾸준히 관리하는 것이 권장된다. 따라서, 세안 시 불필요한 피부 자극을 최소화하고, 외부 자극물질로부터 피부를 보호하며, 실질적인 항균 효과를 나타내는 여드름 치료용 조성물 또는 여드름 피부 개선용 조성물을 개발할 필요가 있다.Acne is often the main cause of the habit, so it is recommended to manage it consistently in daily life. Therefore, there is a need to develop a composition for treating acne or a composition for improving acne skin, which minimizes unnecessary skin irritation during washing, protects the skin from external irritants, and exhibits a substantial antibacterial effect.
본 발명은 상기와 같은 문제를 해결하기 위하여, 여드름 원인균에 대한 항균 효과를 나타내면서 피부 자극을 최소화할 수 있도록 천연물 추출물을 함유하는 여드름 치료용 조성물 또는 여드름 피부 개선용 조성물을 제공하기 위한 것이다.The present invention is to provide a composition for treating acne or a composition for improving acne skin containing a natural extract so as to minimize skin irritation while showing an antibacterial effect against acne causative bacteria in order to solve the above problems.
본 발명은 생강 추출물, 녹차잎 추출물, 쇠비름 추출물, 오이 추출물, 병풀 추출물 및 브로콜리 추출물을 포함하는 여드름 치료용 조성물 또는 여드름 피부 개선용 조성물에 관한 것이다.The present invention relates to a composition for treating acne or a composition for improving acne skin, including a ginger extract, a green tea leaf extract, a purslane extract, a cucumber extract, a centella asiatica extract and a broccoli extract.
본 발명의 조성물은 추가로 트레할로스를 포함할 수 있다.The composition of the present invention may further comprise trehalose.
본 발명의 조성물에서 상기 생강 추출물, 녹차잎 추출물, 쇠비름 추출물, 오이 추출물, 병풀 추출물 및 브로콜리 추출물은 전체 조성물에 대하여 각각 0.5 내지 5중량%를 포함할 수 있다. 또는 본 발명의 조성물에서 상기 생강 추출물, 녹차잎 추출물, 쇠비름 추출물, 오이 추출물, 병풀 추출물 및 브로콜리 추출물의 총합은 전체 조성물 중 3 내지 30중량%의 양으로 포함될 수 있다.In the composition of the present invention, the ginger extract, green tea leaf extract, purslane extract, cucumber extract, centella extract and broccoli extract may contain 0.5 to 5% by weight, respectively, based on the total composition. Alternatively, in the composition of the present invention, the total amount of the ginger extract, green tea leaf extract, purslane extract, cucumber extract, centella extract and broccoli extract may be included in an amount of 3 to 30% by weight of the total composition.
상기 생강 추출물, 녹차잎 추출물, 쇠비름 추출물, 오이 추출물, 병풀 추출물 및 브로콜리 추출물은 물, 유기용매 또는 이들의 혼합물로부터 추출될 수 있다. 예를 들어, 생강 추출물, 녹차잎 추출물, 쇠비름 추출물, 오이 추출물, 병풀 추출물 및 브로콜리 추출물은 각각 생강, 녹차잎, 쇠비름, 오이, 병풀 및 브로콜리를 물, 메탄올, 에탄올, 에틸아세테이트 및 헥산으로 이루어진 군으로부터 선택된 1종 또는 2종 이상의 혼합물을 추출 용매로 하여 냉침법, 온침법 또는 항온진공추출법 등의 방법으로 추출할 수 있다. 바람직하게는 물, 에탄올 또는 물과 에탄올의 혼합물을 추출용매로 사용한다.The ginger extract, green tea leaf extract, purslane extract, cucumber extract, centella extract and broccoli extract may be extracted from water, an organic solvent, or a mixture thereof. For example, ginger extract, green tea leaf extract, purslane extract, cucumber extract, centella extract, and broccoli extract are the group consisting of ginger, green tea leaf, purslane, cucumber, centella and broccoli, respectively, water, methanol, ethanol, ethyl acetate, and hexane It can be extracted by a method such as a cold precipitation method, a warm precipitation method, or a constant temperature vacuum extraction method using one or a mixture of two or more selected from as an extraction solvent. Preferably, water, ethanol, or a mixture of water and ethanol is used as the extraction solvent.
이 때, 상기 각 추출물은 각 천연물(즉, 생강, 녹차잎, 쇠비름, 오이, 병풀 및 브로콜리 각각)로부터 독립적으로 추출되거나, 또는 생강, 녹차잎, 쇠비름, 오이, 병풀 및 브로콜리를 모두 혼합한 후 이 혼합물로부터 동시에 추출될 수 있다.At this time, each extract is independently extracted from each natural product (i.e., ginger, green tea leaves, purslane, cucumber, centella asiatica and broccoli, respectively), or after mixing all of ginger, green tea leaves, purslane, cucumber, centella asiatica, and broccoli It can be extracted simultaneously from this mixture.
본 발명의 조성물은 액상 제형, 현탁제 또는 에멀전 조성물 등으로 제제화될 수 있다. 바람직하게는 에멀전 조성물로 제제화된다.The composition of the present invention may be formulated as a liquid formulation, suspension or emulsion composition. It is preferably formulated as an emulsion composition.
본 발명의 조성물은 여드름 치료용 약제 또는 화장료 또는 세정용으로 사용될 수 있다.The composition of the present invention may be used as an acne treatment drug or cosmetic or cleaning agent.
본 발명의 조성물은, 생강, 녹차잎, 쇠비름, 오이, 병풀 및 브로콜리를 별도로 각각 추출 용매에 넣고, 가온, 실온 또는 냉온에서 추출하는 단계(a); 상기 단계(a)로부터 수득한 추출물을 건조하여 고형 추출물을 수득하는 단계(b); 및 생강, 녹차잎, 쇠비름, 오이, 병풀 및 브로콜리 각 고형 추출물을 혼합하는 단계(c)를 포함하여 제조될 수 있다.The composition of the present invention comprises the steps (a) of separately adding ginger, green tea leaves, purslane, cucumber, centella asiatica and broccoli into an extraction solvent, respectively, and extracting at warm, room temperature, or cold temperature; (B) drying the extract obtained from step (a) to obtain a solid extract; And mixing the solid extracts of ginger, green tea leaves, purslane, cucumber, centella asiatica and broccoli.
여기에서, 상기 추출 용매로는 물, 메탄올, 에탄올, 에틸아세테이트 및 헥산으로 이루어진 군으로부터 선택된 1종 또는 2종 이상의 혼합물이 사용될 수 있다.Here, as the extraction solvent, one or a mixture of two or more selected from the group consisting of water, methanol, ethanol, ethyl acetate, and hexane may be used.
여기에서 상기 단계 (c)는, 상기 생강, 녹차잎, 쇠비름, 오이, 병풀 및 브로콜리 각 추출물을 유기용매에 용해시키는 단계; 및 상기 생강, 녹차잎, 쇠비름, 오이, 병풀 및 브로콜리 각 추출물이 용해된 유기용매를 계면활성제(예를 들어, 트레할로스 등)와 함께 물에 넣어 유화시켜 에멀전 조성물을 제조하는 단계를 포함할 수 있다.Here, the step (c) includes dissolving the extracts of ginger, green tea leaves, purslane, cucumber, centella and broccoli in an organic solvent; And emulsifying an organic solvent in which extracts of ginger, green tea leaves, purslane, cucumber, centella and broccoli are dissolved in water together with a surfactant (for example, trehalose) to prepare an emulsion composition. .
또한, 본 발명의 조성물은 생강, 녹차잎, 쇠비름, 오이, 병풀 및 브로콜리를 모두 추출 용매에 넣고, 가온, 실온 또는 냉온에서 추출하는 단계(a); 상기 단계(a)로부터 수득한 추출물을 건조하여 고형 추출물을 수득하는 단계(b); 및 상기 고형 추출물을 포함하는 조성물을 제조하는 단계(c)를 포함하여 제조될 수 있다.In addition, the composition of the present invention includes the steps (a) of putting ginger, green tea leaves, purslane, cucumber, centella asiatica and broccoli all in an extraction solvent, and extracting at warm, room temperature or cold temperature; (B) drying the extract obtained from step (a) to obtain a solid extract; And it may be prepared including the step (c) of preparing a composition comprising the solid extract.
여기에서, 상기 추출 용매는 물, 메탄올, 에탄올, 에틸아세테이트 및 헥산으로 이루어진 군으로부터 선택된 1종 또는 2종 이상의 혼합물이 사용될 수 있다.Here, the extraction solvent may be one or a mixture of two or more selected from the group consisting of water, methanol, ethanol, ethyl acetate, and hexane.
또한, 여기에서 상기 단계 (c)는, 상기 생강, 녹차잎, 쇠비름, 오이, 병풀 및 브로콜리의 고형 추출물을 유기용매에 용해시키는 단계; 및 상기 생강, 녹차잎, 쇠비름, 오이, 병풀 및 브로콜리의 고형 추출물이 용해된 유기용매를 계면활성제(예를 들어, 트레할로스 등)와 함께 물에 넣어 유화시켜 에멀전 조성물을 제조하는 단계를 포함할 수 있다.In addition, the step (c) here, the step of dissolving the solid extract of the ginger, green tea leaves, purslane, cucumber, centella and broccoli in an organic solvent; And emulsifying an organic solvent in which solid extracts of ginger, green tea leaves, purslane, cucumber, centella and broccoli are dissolved in water together with a surfactant (for example, trehalose, etc.) to prepare an emulsion composition. have.
생강(Zingiber officinale)은 외떡잎 식물 생강목 생강과의 여러해살이풀로서, 뿌리가 식용 및 약용으로 사용되며, 위액 분비 촉진 및 소화력 증진에 효과가 있는 것으로 알려져 있다.Ginger (Zingiber officinale) is a perennial plant of the ginger family Ginger family, a monocotyledonous plant, and its roots are used for edible and medicinal purposes, and are known to be effective in promoting gastric juice secretion and enhancing digestive power.
녹차잎은 차나무(Camellia sinensis)의 잎으로서, 항산화 효과가 있는 것으로 알려져 있다.Green tea leaves are the leaves of the tea tree (Camellia sinensis) and are known to have antioxidant effects.
쇠비름(Portulaca oleracea)은 쌍떡잎식물 중심자목 쇠비름과의 한해살이풀로서, 전초를 말린 것이 약용으로 사용되며, 동맥경화의 예방 등에 효능이 있는 것으로 알려져 있다.Purslane (Portulaca oleracea) is a perennial plant of the family Purslane family, a dicotyledonous plant, and dried outpost is used for medicinal purposes, and is known to be effective in preventing arteriosclerosis.
오이(Cucumis sativus)는 쌍떡잎식물 합판화군 박목 박과의 한해살이 덩굴식물로서, 열매가 식용으로 사용되며, 체내 노폐물 배출의 효능이 있는 것으로 알려져 있다.Cucumi (Cucumis sativus) is a perennial vine plant in the family Plywood group of dicotyledons. The fruit is used for food and is known to be effective in discharging waste products from the body.
병풀(Centella asiatica)은 쌍떡잎식물 이판화군 산형화목 미나리과의 여러해살이풀로서, 전초를 말린 것이 약용으로 사용되며, 위점막을 보호하는 효능이 있는 것으로 알려져 있다.Centella asiatica is a perennial plant of the Aperaceae family of umbela in the dicotyledonous plant Ipanhwa group. Dried outposts are used for medicinal purposes and are known to have the effect of protecting the gastric mucosa.
브로콜리(Brassica oleracea var. italica)는 쌍떡잎식물 양귀비목 겨자과의 한해살이풀로서, 줄기의 끝에 메달리는 작은 꽃뭉치를 식용 또는 약용으로 사용하며, 칼슘의 흡수를 촉진하여 뼈의 건강을 돕는 것으로 알려져 있다.Broccoli (Brassica oleracea var. italica) is an annual plant of the mustard family of the dicotyledonous plant Poppy.Italica is known to help bone health by promoting the absorption of calcium by using a small flower cluster attached to the end of the stem for food or medicinal purposes.
본 발명에 따른 조성물은 천연물 추출물을 함유하는 것으로서, 여드름 원인균에 대한 항균 효과를 나타내면서 피부 자극을 최소화할 수 있어서 안전하다. The composition according to the present invention contains a natural extract, and is safe because it can minimize skin irritation while showing an antibacterial effect against acne-causing bacteria.
도 1은 본 발명에 따른 조성물의 항균력을 디스크 확산법으로 시험한 결과를 촬영한 사진이다.
도 2는 본 발명에 따른 조성물의 항균력을 광학 분석으로 시험한 결과를 촬영한 사진 및 그래프이다.1 is a photograph of the results of testing the antimicrobial activity of the composition according to the present invention by the disk diffusion method.
2 is a photograph and a graph taking the results of testing the antibacterial activity of the composition according to the present invention by optical analysis.
이하, 본 발명을 실시예에 의해 상세히 설명한다. 단, 하기 실시예는 본 발명을 예시하는 것일 뿐, 본 발명의 사상 및 범위가 하기 실시예에 의해 한정되는 것은 아니다.Hereinafter, the present invention will be described in detail by examples. However, the following examples are merely illustrative of the present invention, and the spirit and scope of the present invention are not limited by the following examples.
실시예 1: 천연물 추출Example 1: natural product extraction
생강 100g을 물로 세척한 후, 건조시킨다. 건조된 것을 분쇄기(중국 Yunbang 사의 Pulverizer 2500A 분쇄기)로 분쇄한다. 이 분쇄물을 70% 에탄올 3ℓ에 넣고, 상온에서 교반하면서 5일간 침출한다. 침출액을 1000rpm으로 원심분리한 후 상층액을 회수하여 여과하고, 여액을 건조하여 고형의 추출물(extract) 10g을 수득하였다.After washing 100 g of ginger with water, it is dried. The dried product is pulverized with a pulverizer (Pulverizer 2500A pulverizer manufactured by Yunbang, China). This pulverized product was put into 3 L of 70% ethanol, and leached for 5 days while stirring at room temperature. After centrifuging the leachate at 1000 rpm, the supernatant was collected and filtered, and the filtrate was dried to obtain 10 g of a solid extract.
녹차잎, 쇠비름, 오이, 병풀 및 브로콜리에 대해서도 위와 같은 공정을 통하여 추출물을 각각 9g, 10g, 11g, 9g 및 9g을 수득하였다.For green tea leaves, purslane, cucumber, centella and broccoli, 9g, 10g, 11g, 9g and 9g of extracts were obtained through the same process as above.
실시예 2: 지표물질의 확인Example 2: Identification of indicator substances
상기 실시예 1에서 수득한 각각의 추출물을 헥산 및 에틸아세테이트로 정제하였다. 정제된 각각의 추출물에 대하여 HPLC를 사용하여 지표 물질을 분리하여 확인하였다.Each extract obtained in Example 1 was purified with hexane and ethyl acetate. For each of the purified extracts, an indicator substance was separated and confirmed using HPLC.
HPLC 분석조건은 다음과 같다:HPLC analysis conditions are as follows:
컬럼 : 안지름 약 3mm, 길이 25cm인 스테인레스 강관에 공경 5㎛의 SUPELCOSILTM LC-NH2 HPLC 컬럼 (Sigma-Aldrich)Column: SUPELCOSIL TM LC-NH2 HPLC column (Sigma-Aldrich) with a pore diameter of 5 μm in a stainless steel pipe with an inner diameter of about 3 mm and a length of 25 cm.
이동상 : 메탄올-3차증류수 (46:35, v/v) (degassifying)Mobile phase: methanol-3 distilled water (46:35, v/v) (degassifying)
유속 : 1.1 mL/minFlow rate: 1.1 mL/min
칼럼온도 : 22 ℃Column temperature: 22 ℃
주입량 : 50 ㎕Injection volume: 50 µl
검출기 및 파장 : UV 흡광광도계 310 ㎚ (Bio-Rad)Detector and wavelength: UV absorbance photometer 310 ㎚ (Bio-Rad)
각각의 지표물질은 다음과 같다:Each indicator substance is as follows:
실시예 3: 에멀전 조성물 제조Example 3: Preparation of emulsion composition
하기 표 2의 조성 및 함량으로 100ml 용량의 조성물을 다음과 같이 제조한다:A composition of 100 ml volume is prepared as follows in the composition and content of Table 2 below:
먼저, 유상부의 각 성분을 혼합하여 유상부 혼합물을 제조한다. 여기에 활성부(즉, 상기 실시예 1에서 수득한 각 고형 추출물)를 넣어 80℃로 가열하고, 220 bar 의 압력을 가하여 저속회전으로 교반하면서 용해시킨다.First, each component of the oil phase is mixed to prepare an oil phase mixture. The active part (that is, each solid extract obtained in Example 1) was added thereto, heated to 80° C., and dissolved while stirring at low speed by applying a pressure of 220 bar.
별도로 수상부의 각 성분을 혼합한 수상부 혼합물에 상기 각 고형 추출물이 용해된 유상부를 계면활성제와 함께 가한 후, 75℃ 온도로 유지하면서 정제수로 100ml이 되도록 표선한다. 이 혼합물을 75℃ 온도로 유지하면서, 저속회전 교반기에서 4시간 교반하여, 본 발명에 따른 에멀전 조성물을 제조한다.Separately, the oil phase in which the solid extracts are dissolved is added to the aqueous phase mixture in which each component of the aqueous phase is mixed together with a surfactant, and then marked to be 100 ml with purified water while maintaining the temperature at 75°C. While maintaining this mixture at a temperature of 75° C., the mixture was stirred for 4 hours in a low-rotating stirrer to prepare an emulsion composition according to the present invention.
실시예 4: C. acnes 에 대한 항균 시험Example 4: Antibacterial test against C. acnes
상기 실시예 3의 에멀전 조성물에 대하여, 여드름균인 C. acnes (Cutibacterium acnes) 항균 시험을 다음과 같이 디스크 확산법으로 실시하였다.With respect to the emulsion composition of Example 3, an antibacterial test of C. acnes (Cutibacterium acnes), which is acne bacteria, was performed by a disk diffusion method as follows.
대조군으로는 생강 고형 추출물, 녹차잎 고형 추출물, 쇠비름 고형 추출물, 오이 고형 추출물, 병풀 고형 추출물 및 브로콜리 고형 추출물(각각 실시예 1에서 제조된 것을 사용함)과 항생제(암피실린)을 단독으로 함유하는 조성물(비교예 1 내지 7)을 사용하였다.As a control, a composition containing a solid extract of ginger, a solid extract of green tea leaf, a solid extract of purslane, a solid extract of cucumber, a solid extract of centella asiatica, and a solid extract of broccoli (each prepared in Example 1) and an antibiotic (ampicillin) alone ( Comparative Examples 1 to 7) were used.
각 대조군(비교예 1 내지 7)의 조성은 하기 표 3과 같다(함량의 단위 (g/100ml)):The composition of each control group (Comparative Examples 1 to 7) is shown in Table 3 below (unit of content (g/100ml)):
콜라겐Hydrolyzed
Collagen
포스페이트Magnesium Ascorbyl
Phosphate
또한, 상기 실시예 3의 조성물에서 계면활성제로서 트레할로스 대신에 수크로스를 사용한 조성물을 대조군(비교예 8)으로서 사용하였다(각 성분의 함량은 동일함).In addition, a composition using sucrose instead of trehalose as a surfactant in the composition of Example 3 was used as a control (Comparative Example 8) (the content of each component was the same).
비교예 8의 조성은 하기 표 4와 같다:The composition of Comparative Example 8 is shown in Table 4 below:
Reinforced Clostridial Medium(RCM)과 Bacteriological agar를 혼합한 플레이트 배지에 C. acnes 균주를 접종한 후, 디스크(지름 8mm)마다 그 안에 실시예 3 및 비교예 1 내지 8의 조성물 중 어느 하나를 30㎕씩 로딩하고, 파라필름으로 플레이트를 단단히 감싸서 산소를 차단시켰다.After inoculating the C. acnes strain in a plate medium mixed with Reinforced Clostridial Medium (RCM) and Bacteriological agar, 30 μl of any one of the compositions of Example 3 and Comparative Examples 1 to 8 was inoculated into each disc (diameter 8 mm). After loading, the plate was tightly wrapped with parafilm to block oxygen.
RCM 배지를 37℃ 인큐베이터 안에서 18시간 배양한 후, 실시예 3의 조성물 및 비교예 1 내지 7의 조성물에 대한 항균활성 억제 반경을 측정하였다. 실험 결과를 하기 표 5 및 도 1에 나타내었다(여기에서 억제반경은 원의 면적에서 디스크 면적을 뺀 값으로서, 단위는 mm2이다).After culturing the RCM medium in a 37° C. incubator for 18 hours, the antimicrobial activity inhibition radius for the composition of Example 3 and the compositions of Comparative Examples 1 to 7 was measured. The experimental results are shown in Table 5 and FIG. 1 (here, the suppression radius is a value obtained by subtracting the disk area from the area of the circle, and the unit is mm 2 ).
가. 각 천연물 추출물의 항균 활성 비교end. Comparison of antibacterial activity of each natural product extract
실험 결과로부터, 각 추출물을 단독으로 사용한 경우(비교예 1 내지 6의 조성물)에는 C. acnes에 대한 항균활성이 거의 나타나지 아니하였으나, 본 발명에 따른 실시예 5의 조성물은 항균 활성이 나타남을 확인할 수 있었다.From the experimental results, when each extract was used alone (compositions of Comparative Examples 1 to 6), antibacterial activity against C. acnes was hardly observed, but it was confirmed that the composition of Example 5 according to the present invention showed antibacterial activity. Could
본 발명에 따른 실시예 3의 조성물이 양성 대조군인 암피실린 항생제의 항균 효과에는 다소 미치지 못하였으나, 항생제 투여 시 내성 발현 등과 같은 부작용이 발생하는 점에 비추어 볼 때, 본 발명의 조성물은 안전한 생약 추출물을 사용하여 부작용이 적으면서도 만족할 만한 항균 활성을 나타낸다는 점을 알 수 있었다.The composition of Example 3 according to the present invention slightly did not reach the antibacterial effect of the positive control, ampicillin antibiotic, but in view of the fact that side effects such as resistance development occur when antibiotics are administered, the composition of the present invention is a safe herbal extract It was found that it showed satisfactory antimicrobial activity with few side effects.
나. 계면활성제 성분에 따른 항균 활성의 차이I. Difference in antibacterial activity according to surfactant component
계면활성제로서 수크로오스를 사용한 경우(비교예 8)에는 C. acnes에 대한 항균활성이 트레할로스를 사용한 실시예 3의 조성물의 항균활성보다 적게 나타났다.When sucrose was used as the surfactant (Comparative Example 8), the antimicrobial activity against C. acnes was less than that of the composition of Example 3 using trehalose.
실시예 5: 항균 활성에 대한 광학적 분석Example 5: Optical analysis for antibacterial activity
C. ances 균주가 108/ml 의 농도로 존재하는 RCM 배지(증류수에 분산된 것) 10ml을 시험관에 넣는다. 여기에, 실시예 3의 조성물 및 비교예 8의 조성물을 각각 최종 혼합물에 대하여 10㎍/ml 또는 30㎍/ml 의 농도가 되도록 넣어 혼합한다. 이 혼합물이 들어 있는 시험관을 37℃ 진탕 인큐베이터 내에서 18시간 배양하였다.10 ml of RCM medium (dispersed in distilled water) in which the C. ances strain is present at a concentration of 10 8 /ml is added to a test tube. Here, the composition of Example 3 and the composition of Comparative Example 8 were added and mixed so as to have a concentration of 10 μg/ml or 30 μg/ml with respect to the final mixture, respectively. The test tube containing this mixture was incubated for 18 hours in a shaking incubator at 37°C.
이후, 흡광도(OD 600nm)를 광학 분석하여, 균주의 농도를 분석하였다. 분석 결과는 도 2에 나타내었다.Then, the absorbance (OD 600nm) was optically analyzed to analyze the concentration of the strain. The analysis results are shown in FIG. 2.
분석 결과, 트레할로스를 사용한 본 발명의 조성물에 대해서 항균 활성이 나타났으나, 수크로스를 사용한 대조군의 조성물에서는 항균 활성이 거의 나타나지 아니하였다.As a result of the analysis, antimicrobial activity was observed for the composition of the present invention using trehalose, but the antimicrobial activity was hardly observed in the composition of the control group using sucrose.
이는 수크로스를 사용하는 경우 유화가 제대로 이루어지지 못하여 항균 활성이 저하되었기 때문인 것으로 추측된다.This is presumed to be due to the fact that the antimicrobial activity was lowered due to poor emulsification when sucrose was used.
이와 같이, 본 발명의 조성물에서 계면활성제로는 트레할로스가 적합하다는 것을 확인할 수 있었다.As described above, it was confirmed that trehalose was suitable as a surfactant in the composition of the present invention.
본 발명의 조성물은 여드름 원인균에 대한 항균 효과를 나타내면서 피부 자극을 최소화할 수 있는 안전한 조성물이다.The composition of the present invention is a safe composition capable of minimizing skin irritation while exhibiting an antibacterial effect against acne causative bacteria.
Claims (14)
상기 단계(a)로부터 수득한 추출물을 건조하여 고형 추출물 수득하는 단계(b);
생강, 녹차잎, 쇠비름, 오이, 병풀 및 브로콜리 각 고형 추출물을 혼합하는 단계(c)를 포함하며,
여기에서, 상기 단계 (c)는,
상기 생강, 녹차잎, 쇠비름, 오이, 병풀 및 브로콜리 각 추출물을 유기용매에 용해시키는 단계; 및
상기 생강, 녹차잎, 쇠비름, 오이, 병풀 및 브로콜리 각 추출물이 용해된 유기용매를 트레할로스와 함께 물에 넣어 유화시켜 에멀전 조성물을 제조하는 단계를 포함하는 것인, 제1항의 여드름 치료용 조성물 또는 제4항의 여드름 피부 개선용 조성물의 제조 방법.(A) adding ginger, green tea leaves, purslane, cucumber, centella asiatica, and broccoli into an extraction solvent, respectively, and extracting at warm, room temperature, or cold temperature;
(B) drying the extract obtained from step (a) to obtain a solid extract;
Including the step (c) mixing each solid extract of ginger, green tea leaves, purslane, cucumber, centella and broccoli,
Here, the step (c),
Dissolving the ginger, green tea leaves, purslane, cucumber, centella asiatica and broccoli extracts in an organic solvent; And
The composition or agent for treating acne of claim 1 comprising the step of preparing an emulsion composition by emulsifying an organic solvent in which the extracts of ginger, green tea leaves, purslane, cucumber, centella and broccoli are dissolved in water together with trehalose A method for preparing a composition for improving acne skin of claim 4.
상기 단계(a)로부터 수득한 추출물을 건조하여 고형 추출물을 수득하는 단계(b);
상기 고형 추출물을 포함하는 조성물을 제조하는 단계(c)를 포함하며,
여기에서, 상기 단계 (c)는,
상기 생강, 녹차잎, 쇠비름, 오이, 병풀 및 브로콜리의 고형 추출물을 유기용매에 용해시키는 단계; 및
상기 생강, 녹차잎, 쇠비름, 오이, 병풀 및 브로콜리의 고형 추출물이 용해된 유기용매를 트레할로스와 함께 물에 넣어 유화시켜 에멀전 조성물을 제조하는 단계를 포함하는 것인, 제1항의 여드름 치료용 조성물 또는 제4항의 여드름 피부 개선용 조성물의 제조 방법.(A) adding ginger, green tea leaves, purslane, cucumber, centella asiatica and broccoli to the extraction solvent, and extracting at warm, room temperature or cold temperature;
(B) drying the extract obtained from step (a) to obtain a solid extract;
Including the step (c) of preparing a composition comprising the solid extract,
Here, the step (c),
Dissolving the solid extracts of the ginger, green tea leaves, purslane, cucumber, centella asiatica and broccoli in an organic solvent; And
The composition for treating acne of claim 1 comprising the step of preparing an emulsion composition by emulsifying an organic solvent in which solid extracts of ginger, green tea leaves, purslane, cucumber, centella and broccoli are dissolved in water together with trehalose and emulsified. A method for producing a composition for improving acne skin of claim 4.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020200078644A KR102170850B1 (en) | 2020-06-26 | 2020-06-26 | A composition for treating acne or improving acne skin |
PCT/KR2021/008052 WO2021261971A1 (en) | 2020-06-26 | 2021-06-26 | Composition for acne treatment or skin improvement |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020200078644A KR102170850B1 (en) | 2020-06-26 | 2020-06-26 | A composition for treating acne or improving acne skin |
Publications (1)
Publication Number | Publication Date |
---|---|
KR102170850B1 true KR102170850B1 (en) | 2020-11-02 |
Family
ID=73397884
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020200078644A KR102170850B1 (en) | 2020-06-26 | 2020-06-26 | A composition for treating acne or improving acne skin |
Country Status (2)
Country | Link |
---|---|
KR (1) | KR102170850B1 (en) |
WO (1) | WO2021261971A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20230171869A (en) | 2022-06-14 | 2023-12-21 | 이승창 | Pharmaceutical composition for prevention or treatment of acne |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR19990000085A (en) | 1997-06-02 | 1999-01-15 | 성재갑 | Acne prevention and treatment composition containing extract |
KR20080006568A (en) * | 2005-03-30 | 2008-01-16 | 레반스 테라퓨틱스, 아이엔씨. | Compositions and methods for treating acne |
JP2011093835A (en) * | 2009-10-29 | 2011-05-12 | Noevir Co Ltd | Skin care preparation |
KR20180017974A (en) * | 2016-08-12 | 2018-02-21 | (주)한국융합기술연구소 | Cosmetic composition for preventing or treating acne comprising combined herbal extracts |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20180137952A (en) * | 2017-06-20 | 2018-12-28 | (주)지유본초 | Mask pack |
-
2020
- 2020-06-26 KR KR1020200078644A patent/KR102170850B1/en active IP Right Grant
-
2021
- 2021-06-26 WO PCT/KR2021/008052 patent/WO2021261971A1/en active Application Filing
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR19990000085A (en) | 1997-06-02 | 1999-01-15 | 성재갑 | Acne prevention and treatment composition containing extract |
KR20080006568A (en) * | 2005-03-30 | 2008-01-16 | 레반스 테라퓨틱스, 아이엔씨. | Compositions and methods for treating acne |
JP2011093835A (en) * | 2009-10-29 | 2011-05-12 | Noevir Co Ltd | Skin care preparation |
KR20180017974A (en) * | 2016-08-12 | 2018-02-21 | (주)한국융합기술연구소 | Cosmetic composition for preventing or treating acne comprising combined herbal extracts |
Non-Patent Citations (1)
Title |
---|
한국식품위생안전성학회지, 2012, 27(4), pp. 461-465* * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20230171869A (en) | 2022-06-14 | 2023-12-21 | 이승창 | Pharmaceutical composition for prevention or treatment of acne |
Also Published As
Publication number | Publication date |
---|---|
WO2021261971A1 (en) | 2021-12-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Fahimi et al. | Wound healing activity of a traditionally used poly herbal product in a burn wound model in rats | |
Khémiri et al. | The antimicrobial and wound healing potential of Opuntia ficus indica L. inermis extracted oil from Tunisia | |
Nasiri et al. | The effects of Punica granatum flower extract on skin injuries induced by burn in rats | |
KR101068151B1 (en) | Composition comprising of plant extract having antimicrobial and antiseptic activity and the use thereof | |
CN108785122A (en) | A kind of anti-acne conveys nano-composition and its preparation method and application altogether | |
Agyare et al. | Medicinal plants used for treatment of wounds and skin infections: assessment of wound healing and antimicrobial properties of Mallotus oppositifolius and Momordica charantia | |
US10765641B2 (en) | Cosmetic composition comprising a combination of pongamia oil and 4-t-butylcyclohexanol for the treatment of rosacea | |
KR102170850B1 (en) | A composition for treating acne or improving acne skin | |
CN105056051A (en) | Plant polypeptide compound gel for treating gynecological diseases and preparation method thereof | |
CN109620879A (en) | A kind of wet repairing paste and preparation method thereof clearly | |
JP6590233B1 (en) | Skin disease therapeutic agent and method for producing the same | |
KR20210048021A (en) | Antibacterial compositions comprising the citrus aurantium sinensis peel extract, the magnolia officinalis bark extract and polylysine | |
KR102581166B1 (en) | Cosmetic composition comprising Dendropanax morbifera Extract for improving acne skin | |
CN114159353A (en) | Honeycomb nose moistening cream for repairing nasal mucosa and preparation method thereof | |
CN108703899B (en) | Skin-care massage essential oil | |
KR20180017974A (en) | Cosmetic composition for preventing or treating acne comprising combined herbal extracts | |
KR100892742B1 (en) | Skin external composition for treating pimple | |
CN109200232A (en) | A kind of antipsoriatics object | |
EP3806878B1 (en) | Herbal compositions for the treatment of urolithiasis and urinary tract infections | |
KR102066821B1 (en) | Natural Complex Cosmetic Preservative Composition | |
CN108096108B (en) | Composition for inhibiting bacteria, eliminating acne and relieving itching and preparation method and application thereof | |
KR20180036024A (en) | A composition comprising Sauropus spatulifolius Beille extracts having anti-inflammation activity | |
CN107714834A (en) | A kind of composition of camellia oil preparation for external use, preparation method and applications | |
KR102381251B1 (en) | Cosmetic composition for anti-oxidation, skin moisturizing, or improving of acne skin or skin trouble containing complex extract of Eriobotryae Folium | |
KR102514212B1 (en) | Cosmetic composition and method for preparing the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant |